Trial intelligence / Profile preview

Quadrivalent HPV Vaccine in Immunosuppressed Children

NCT02263703Phase 3Completed

Sponsor
University of New South Wales
Start
May 2007
Primary completion
Feb 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of qHPV vaccine in human papillomavirus infection, sponsored by University of New South Wales. Started May 2007; status: completed.

02

Drugs

qHPV vaccine
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on NCT02263703.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02263703.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call